Literature DB >> 10312927

Cost of illness studies: no aid to decision making? Comments on the second opinion by Shiell et al. (Health Policy, 8(1987) 317-323).

T A Hodgson.   

Abstract

Mesh：

Year:  1989        PMID： 10312927     DOI： 10.1016/0168-8510(89)90055-9

Source DB:  PubMed          Journal:  Health Policy        ISSN： 0168-8510            Impact factor:   2.980


× No keyword cloud information.
  13 in total

1.  Prostate cancer: 12. The economic burden.

Authors:  S A Grover; H Zowall; L Coupal; M D Krahn
Journal:  CMAJ       Date:  1999-03-09       Impact factor: 8.262

Review 2.  Cost-of-illness studies. Useful for health policy?

Authors:  M A Koopmanschap
Journal:  Pharmacoeconomics       Date:  1998-08       Impact factor: 4.981

3.  The cost of migraine: more than just a headache?

Authors:  P J Davey; S R Leeder
Journal:  Pharmacoeconomics       Date:  1992-07       Impact factor: 4.981

4.  Measuring the externality of antibacterial use from promoting antimicrobial resistance.

Authors:  Klaus Kaier; Uwe Frank
Journal:  Pharmacoeconomics       Date:  2010       Impact factor: 4.981

Review 5.  Cost-of-illness studies : a review of current methods.

Authors:  Ebere Akobundu; Jing Ju; Lisa Blatt; C Daniel Mullins
Journal:  Pharmacoeconomics       Date:  2006       Impact factor: 4.981

6.  Total economic cost and burden of dengue in Nicaragua: 1996-2010.

Authors:  Zachary S Wettstein; Michael Fleming; Aileen Y Chang; David J Copenhaver; Angela R Wateska; Sarah M Bartsch; Bruce Y Lee; Rajan P Kulkarni
Journal:  Am J Trop Med Hyg       Date:  2012-08-13       Impact factor: 2.345

7.  Cost-of-illness studies: a guide to critical evaluation.

Authors:  Allison Larg; John R Moss
Journal:  Pharmacoeconomics       Date:  2011-08       Impact factor: 4.981

Review 8.  Economic evaluations of type II diabetes.

Authors:  B Leese
Journal:  Pharmacoeconomics       Date:  1995       Impact factor: 4.981

9.  Societal perspective on the burden of migraine in The Netherlands.

Authors:  L van Roijen; M L Essink-Bot; M A Koopmanschap; B C Michel; F F Rutten
Journal:  Pharmacoeconomics       Date:  1995-02       Impact factor: 4.981

Review 10.  Cost-of-illness studies in diabetes mellitus.

Authors:  Lorraine Ettaro; Thomas J Songer; Ping Zhang; Michael M Engelgau
Journal:  Pharmacoeconomics       Date:  2004       Impact factor: 4.981
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.